MSH|^~\&||||UCHUHCP|20201111124943|EDICOPATHI|ORR^O02|58579|P|2.4|||AL|NE
PID|1||40800000^^^MRENTR^MEDREC||ORANG^BLOD^^^^^D||19890909|F|||^^^^^ENGLAND^
NTE|1||COVID-19-SHIELDING PT\T\ A MINOR-APPROVED-PP
NTE|2
NTE|3||12/6for15/6ad
ORC|CR|10004000^EPC||UH20-4444|||^^^20201109150300^^R||20201111124941|EDICOPATHI^INTERFACE^COPATH^RESULTS IN||SRS^BIG^BIRD^^^^^^CONS^^^^CONS|CTYA^MCC G03 TYA DC^DEPID^10203^^^^^MCC G03 TYA DC|||||DTPDS4HK1232^DTPDS4HK1232|||||||||||I
OBR|1|10004000^EPC|UH20-4444^CoPathPlus|UH^Histopathology||20201109150300|20201109150500|||1232231^MARIO^M|Lab Collect|||20201110141900|BM&Bone Marrow|SRS^BIG^BIRD^^^^^^CONS^^^^CONS||||UH20-4444||||Path,Cyt|||^^^20201109150300^^R|||||||||20201109150300
NTE|1||How many labels to print?->2
NTE|2||Clinical Details:->aml relapse
NTE|3||Is this the patient's first biopsy on the cancer pathway?->No
